Cancer BioMarker vaccine

A Cancer Biomarker Vaccine is a type of vaccine designed to target specific molecules, proteins, or genetic markers that are indicative of cancer cells. These biomarkers can be unique to cancer cells or overexpressed compared to normal cells, making them potential targets for therapy.

The concept behind this vaccine is to stimulate the body's immune system to recognize and attack cells displaying these specific biomarkers, thereby targeting and destroying cancerous cells while sparing healthy ones. Essentially, it's a form of immunotherapy, harnessing the body's own immune defenses to fight cancer.

    Related Conference of Cancer BioMarker vaccine

    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia
    July 28-29, 2025

    43rd Euro Global Summit and Expo on Vaccines & Vaccination

    Aix-en-Provence, France
    September 18-19, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    October 06-07, 2025

    37th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada

    Cancer BioMarker vaccine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in